Obesity Clinical Trial
Official title:
Is MyPlate.Gov Approach to Helping Overweight Patients Lose Weight More Patient-centered?
| Verified date | October 2017 |
| Source | University of California, Los Angeles |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Investigators from the University of California-Los Angeles (UCLA) and The Children's Clinic
of Long Beach (TCC) are conducting a randomized, controlled comparative effectiveness trial
of two government-sanctioned behavior change approaches to weight control with TCC's obese
patients. The first approach is the calorie-counting calorie restriction (CC) approach used
in the Diabetes Prevention Program. The second approach is the high-satiation/high-satiety
approach represented by MyPlate.gov. The MyPlate nutritional goal is to double patient fruit
and vegetable intake, legume intake, and whole grain intake. Both conditions stipulate 150
minutes of moderate physical activity a week. Study participants will be 300 of TCC's obese
patients, 76% of whom are expected to be Latino, 13% African American and 11% Other
Ethnicities.
The interventions will be implemented by trained community lifestyle change coaches with
brief support from clinicians. The interventions will include two home visits, two group
education sessions and seven telephone behavior change coaching sessions.
Compared to the CC approach, the MyPlate approach is hypothesized to yield better 12 months
patient-centered outcomes, particularly self-reported satiety.
| Status | Completed |
| Enrollment | 261 |
| Est. completion date | July 31, 2017 |
| Est. primary completion date | March 23, 2017 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Must be overweight (BMI > 25) or obese adult patient at The Childrens Clinic of Long Beach (TCC), - interested in achieving desirable weight loss through behavior change. - speak English or Spanish. Exclusion Criteria: - Smoking in last 6 months, - Currently pregnant, - Medical condition preventing voluntary change in food choices or level of daily physical activity, - Planning on moving out of the Long Beach area in the next two years. - MyocardiaI Infarction, stroke or atherosclerotic cardiovascular disease procedure within the last 6 months - Serious medical condition likely to hinder accurate measurement of weight, or for which weight loss is contraindicated, or which would cause weight loss (e.g. End Stage Renal Disease on dialysis, cancer diagnosis or treatment within 2 yrs) - Prior or planned bariatric surgery - Use of prescription weight loss medication (including off label drugs e.g. topiramate, bupropion, byetta) or over-the-counter orlistat within 6 months - Chronic use (at least past 6 months) of medications likely to cause weight gain or prevent weight loss (e.g. corticosteroids, lithium, olanzapine, risperidone, clozapine) - Unintentional weight loss within past 6 months (= 5% of body weight) - Intentional weight loss within past 6 months (= 5% of body weight) - Pregnant or nursing within past 6 months - Plans to become pregnant within 18 months - Another member of household is a study participant or trial staff member - Problem alcohol use: Self reported average consumption of > 14 alcoholic drink per week or 5+ drinks on any occasion in past week? for males and >7 drinks per week or 4+ drinks on any occasion in the past week for females - Psychiatric hospitalization in last year - Unstable angina - Blood pressure >160/100 (note: individuals may be rescreened) |
| Country | Name | City | State |
|---|---|---|---|
| United States | The Children's Clinic of Long Beach (TCC) | Long Beach | California |
| United States | UCLA Center for Cancer Prevention & Control Research | Los Angeles | California |
| Lead Sponsor | Collaborator |
|---|---|
| University of California, Los Angeles | Patient-Centered Outcomes Research Institute |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Patient-centered Outcome Measure = Self-reported Hunger | Response to question: "Thinking about yesterday, how hungry did you feel during the day?" Response was a mark on a 100mm scale or oral response on a scale from 0 to 100 (for participants assessed via phone), 0="Not at all hungry" and 100="Extremely hungry." | 12 months follow-up | |
| Primary | Medical Outcome Measure = Body Weight | Body weight, measured in kilograms, was obtained by having shoeless participants dressed in light clothing stand on a regularly calibrated medical scale. Measures were taken twice. If these measures differed by more than 0.2 kg, a third measure was taken and averaged with the other two. | 12 months follow-up | |
| Primary | Meal Satisfaction Yesterday | "Take a moment to think about the last meal you ate yesterday. Thinking about the last meal you ate, how satisfied were you after the meal?" Response was a mark on a 100 mm visual analogue scale or response to oral question on a scale from 0 to 100 (for participants assessed via phone), with the low end (0) anchored by "Very satisfied" and the high end (100) anchored by "Very unsatisfied." For analysis purposes this measure was reverse-scored, so that higher values represented greater meal satisfaction. | 12 months follow-up | |
| Primary | Feeling Full After Last Meal Yesterday | "Take a moment to think about the last meal yesterday. Thinking about the last meal you ate, how full did you feel after that meal?" Response was a mark on a 100 mm visual analogue scale (VAS), or oral response to question on a scale from 0 to 100 (for participants assessed via phone), 0="Extremely full" and 100="Not at all full." For analysis purposes this measure was reverse-scored, so that higher values represented greater fullness. | 12 months follow-up | |
| Secondary | Systolic Blood Pressure | Systolic blood pressure assessed on participant's left arm while participant is seated, after at least 5 minutes of rest. Automated, regularly calibrated sphygmomanometer was used with oversize cuffs for obese arms. | 12 months follow-up | |
| Secondary | Body Mass Index | Body mass index is weight in kilograms divided by the square of the participant's height measured in meters. Wall-mounted stadiometer was used to assess height. Weekly-calibrated, portable, digital scales were used to assess body weight. | 12 months follow-up | |
| Secondary | Waist Circumference | The waist circumference was assessed using research standard waist circumference measuring tapes. The result was measured to closest 0.1 cm. The assessor was instructed to position the measuring tape horizontally around the waist, just above the iliac crest. | 12 months follow-up |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |